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INTRODUCTION 
 
 
                     The respiratory tract serves the dual purpose of 
supplying oxygen to and removing carbon dioxide from the 
circulating blood and is likely to develop all neoplastic and non-
neoplastic diseases.  Patients with diseases of the respiratory 
system generally present because of symptoms, an abnormality 
on a chest radiograph or both. 
 
  The diagnostic modalities available for assessing 
the patient with suspected or known respiratory system disease 
include imaging studies and techniques for acquiring biopsy 
specimens, some of which involve direct visualisation of part of 
respiratory system. 
 
 Bronchoscopy is one among such procedures which not 
only visualizes the respiratory system but also aids in obtaining 
the representative sampling material from the regions that are 
directly visualised and also from the more distal pulmonary 
parenchyma. 
 
 BAL is one among several techniques which provides 
sequential access to well preserved cells to study the natural 
history of the disease process. 
 
 As an investigative tool BAL has enormous potential. BAL 
has been found useful in diagnosing opportunistic infections in 
the lung, bronchoalveolar hemorrhage and alveolar proteinosis.  
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BAL has also been used to investigate the pathogenesis 
of such diverse lung conditions such as emphysema, ARDS, 
occupation lung disease, drug hypersensitivity reactions and 
asthma. 
 
 The cytological examination of cells obtained by BAL has 
been useful in the diagnosis of primary bronchogenic cancer 
and the metastatic cancer to the lung in particular lymphangitic 
carcinomatosis. 
 
 This study aims at studying the bronchoalveolar lavage 
samples obtained from the lungs in various pulmonary lesions 
and its histopathological correlation. 
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                                       AIM OF STUDY 
 
 
1. To evaluate the broncho alveolar lavage sample of 
patients presented with respiratory symptoms such as 
cough, fever, hemoptysis, breathlessness and weight 
loss. 
 
 
2. To study the abnormal smears and correlate the 
cytological finding with histopathological diagnosis 
 
3. To assess the usefulness of the cytological study in the 
diagnosis of pulmonary lesions. 
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HISTORICAL ASPECTS 
 
 
                     Rigid bronchoscope was introduced in 1895 by 
Gustav Killian (1860-1921) in Germany. In 1897, Killian 
demonstrated first clinical application bronchoscope when he 
removed the piece of bone from right bronchus. He actually 
used rigid esophagoscope and a long forceps to do that. He is 
considered to be the “Father of bronchoscope”. 
 
                     In 1904, Chevalier Jackson equipped the 
bronchoscope with an electric light source at the distal end and 
also added the suction channel. 
 
                     Early in 1960, Japanese physician Shigeto Ikeda 
devised the means to replace the small electric bulb with glass 
fibers capable of transmitting brighter light from an outside 
source 
 
                     He presented the first flexible bronchoscope at the 
International congress on diseases of the chest in Copenhagen 
(1996). 
 
                     At the end of 1980s Asahi Pentax replaced the 
fibreoptic bundle with a charge coupled sensor at the tip of the 
scope. This video bronchoscope allowed the bronchoscopist to 
look at the monitor screen instead of through the eyepiece of 
the scope 
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Johnston and Frable (1845) stated that Exfoliative 
cytology was first used to study cells of the respiratory tract 41. 
 
 Linder J. revealed its ability to diagnose malignancy as 
early as 1919 51, but it was not until 1950s and 1960s, that it 
was developed into a viable diagnostic modality. 
 
In 1920, BAL was originally developed as a therapeutic 
procedure in the management of phosgene poisoning and also 
for treatment of pulmonary alveolar proteinosis and asthma. 
 
In 1954, in the introduction of his famous Atlas of 
Exfoliative cytology, Geroge N. Papanicolaou comments that 
the use of the cytologic method in the diagnosis of malignant 
lesions of the respiratory tract has been generally acclaimed as 
one of its most success applications. 
 
Rigid bronchoscopic biopsy was the standard method of 
obtaining specimens for definitive diagnosis as a basis for 
management until the advent of flexible fibreoptic bronchoscopy 
in 1960s. 
 
         Dahlgren S. S. Nordenstron B stated that cytology was 
bolstered by the introduction of direct sampling methods via 
bronchoscopy and thoracic Fine Needle Aspiration (FNA) 
resulting in an armamentarium of sampling techniques. 
 
          In 1965 BAL was introduced initially as a therapeutic 
procedure to clear the alveolar spaces of accumulated 
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secretions blocking gaseous exchange, for example in alveolar 
proteinosis and bronchial asthma67. 
 
          Subsequently in 1984, the technique has been used for 
diagnostic purposes primarily in suspected pneumocystis carinii 
pneumonia, replacing open lung biopsy 25 and in 1987 in the 
diagnosis of interstitial lung disease (Stoller). 
 
         In 1985, it has been used to identify various other 
bacterial, fungal, parasitic, and sometimes viral agents causing 
pulmonary infections, particularly in patients with acquired 
immunodeficiency syndrome (AIDS) 13, 46, 71 and children with 
chronic granulomatous disease, an inherited defect of 
phagocytic oxidative enzymes. 
 
        In 1999 it has also been reported of value in investigating 
and monitoring other inflammatory reactions in the lung, for 
example ozone injury of the alveolar epithelium 10 , bronchiolitis 
obliterans organizing pneumonia (BOOP)47 and chronic 
pulmonary diseases, mainly sarcoidosis and various forms of 
pulmonary pneumoconiosis. 
 
          In patients suspected radiologically of having pulmonary 
alveolar microlithiasis, a rare disease characterized by the 
presence of alveolar calcospherites, the calcospherites can be 
demonstrated in BAL fluid 55. 
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  BAL may sometimes disclose an unsuspected 
carcinoma particularly bronchioloalveolar carcinoma, which may 
mimic diffuse inflammatory lung disease radiologically and has 
been reported in patients monitored after lung transplantation 28.  
 
         Quantization of lipid laden macrophages has been 
proposed as an index of aspiration pneumonitis 20.  
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EMBRYOLOGY 
 
The respiratory system develops from the median 
diverticulum of foregut. The lining epithelium is therefore of 
endodermal origin. The connective tissue, cartilage and muscle, 
in relation to the organs of respiration are derived from 
splanchno – pleuric mesoderm. 
 
Developmentally, the respiratory system is an outgrowth 
from the ventral wall of the foregut.  The midline trachea 
develops two lateral outpocketings, the lung buds.  The right 
lung bud eventually divides into three branches - the main 
bronchi - and the left into two main bronchi, thus giving rise to 
three lobes on the right and two on the left. 
 
          The lingula on the left is the middle lobe equivalent; 
however, the left lung is smaller than the right.  The right main 
stem bronchus is more vertical and more directly in line with the 
trachea than the left. 
 
           The main right and left bronchi branch dichotomously, 
giving rise to progressively smaller airways.  Accompanying the 
branching airways is the double arterial supply to the lungs that 
is the pulmonary and bronchial arteries. 
 
During fetal life, all subdivisions of the bronchial tree are 
lined by cubical epithelium. With the onset of respiration after 
birth, the alveoli become dilated and the lining epithelium 
becomes thinned. 
 9 
The pulmonary circulation is established early in fetal life. 
However most of the blood is short circuited through the 
foramen ovale and ductus arteriosus. The amount of blood 
circulating through the lungs progressively increases and by the 
seventh month of intrauterine life the circulation is rich enough 
to provide adequate oxygen for sustaining life. Hence an infant 
born thereafter is viable.  
 
 
ANATOMY 
  
 
The respiratory tract can be categorized into upper and 
lower compartments.  The upper airway extends from the sino-
nasal area to the larynx.  The lower respiratory tract which is the 
major focus of diagnostic respiratory cytopathology extends 
from the trachea to the lungs. 
 
               The tracheo bronchial tree divides progressively into 
smaller airways. Progressive branching of bronchi forms 
bronchioles which are distinguished from the bronchi by the lack 
of cartilage and sub mucosal glands within their walls. 
 
                Further branching of bronchioles leads to terminal 
bronchioles which are less than 2mm in diameter. The part of 
the lung distal to the terminal bronchiole is called the acinus. It 
is approximately spherical with diameter of about 7 mm. 
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                An acinus is composed of respiratory bronchiole, 
which gives off several alveoli from their sides. These 
bronchioles then proceed into the alveolar ducts, which 
immediately branch into alveolar sacs. 
  
CELLULAR COMPONENTS OF THE RESPIRATORY 
TRACT 
 
                The trachea and bronchi are lined by pseudo stratified 
columnar epithelium.  The predominant cell, the ciliated 
columnar cell, has a basal nucleus and finely granular 
chromatin. 
 
               At a ratio of approximately one per six ciliated cells, 
are goblet cells, with basally located nuclei and cytoplasm 
distended by mucus.  
 
               Adjacent to the basement membrane, are basal or 
reserve cells. They are small, undifferentiated cells that are 
presumed fore runners of the ciliated and goblet cells. 
 
              Neuroendocrine or (Feyrter or K Cells) kulchitsky cells 
are also present in the respiratory epithelium but cannot be 
identified with routine stains. 
 
                The terminal bronchioles are lined by predominantly 
non-ciliated cuboidal to columnar cells called Clara cells, 
usually not recognized on cytologic preparations. 
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                The alveolar lining consists of type I and type II 
pneumocytes.  Type I pneumocytes, which are more numerous, 
are paper thin, and cover the gas exchange portion of the 
alveolar surface. 
 
                 Type II pneumocyte is plumper and more 
conspicuous, being cuboidal rather than flat.  After lung injury, 
these cells function as reserve cells for the delicate type I 
pneumocyte. 
 
 
                 Alveolar macrophages, loosely attached to the 
epithelial cells or lying free within the alveolar spaces, derived 
from blood monocyte and belonging to the mononuclear 
phagocytic system.  Often they are filled with carbon particles 
and other phagocytosed materials. 
 
GENERAL CYTOLOGICAL FINDINGS IN RESPIRATORY 
SAMPLES: 
 
Squamous cells 
 
Superficial and intermediate cells predominate in Pap 
stained smears.  The intermediate cells are characterized by a 
round to oval vesicular nucleus, embedded in a uniform thin 
cyanophilic cytoplasm.  The superficial cells have pyknotic 
nucleus and orangeophilic cytoplasm. 
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Bronchial Epithelial Cells 
 
Columnar or triangular in shape, the cells lie singly, in 
short ribbons or in flat sheets often have anatomical straight 
edge.  
 
 They have delicate cyanophilic cytoplasm.  Nuclei vary 
considerably in size and shape, but are usually basal and 
rounded or oval, with open granular condensed chromatin and 
single small nucleoli.  Multi nucleation may be seen. 
 
Cilia are often still preserved, arising from a dark stained 
terminal bar at the broader end of the cell. 
 
Goblet cells 
 
These are columnar cells but distended centrally by 
globules of mucin which overlie or displace the nucleus. 
 
Reserve cells 
 
They form sheets of small regular cells slightly larger than 
lymphocytes with high nuclear cytoplasmic ratio, coarse 
chromatin and a narrow rim of cytoplasm. 
 
Macrophages 
 
Round or oval dissociated cells.  The cytoplasm is poorly 
defined, cyanophilic and often vacuolated, phagocytosed 
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material usually carbon may be present (Fig 1).  They have 
central or eccentric nuclei, rounded or bean-shaped, with 
coarse chromatin and visible nucleoli. 
 
          Inflammatory cells, mainly polymorphonuclear leucocytes 
and lymphocytes, are invariably present in low numbers and are 
only of diagnostic significance if markedly increased. 
 
              Harmsen et al (1985) have shown that labeled particles 
instilled into the lung are not passively transported across the 
alveolar membrane but are phagocytosed by alveolar 
macrophages and then migrate to lymph nodes34.  
 
Macrophages are the most numerous of cells recovered 
by lavage; phenomenal numbers are derived from the alveolar 
spaces in cigarette smokers. 
 
  In the normal non smoker, lymphocytes are the next 
most numerous cell followed by neutrophils and ciliated 
epithelial cells.  
 
 In cigarette smokers neutrophils are elevated in number 
as the result of airway irritation.  
 
In both smokers and non smokers a small percentage of 
oropharyngeal derived squamous epithelial cells are normally 
present particularly in the bronchial specimen 50. 
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NON CELLULAR INANIMATE COMPONENTS IN CYTOLOGY 
SPECIMEN: 
 
Asbestos fibers are composed of variable amounts of 
silica, magnesium and iron.  In 1968, Gross P et al revealed 
that Ferruginous bodies were formed when filamentous dust 
particles such as asbestos becomes coated with protein and 
iron in the lung parenchyma31. 
 
 Gleich G (1977) stated in his book that Charcot leyden 
crystals were derived from the breakdown products of 
eosinophil granules, which would appear in conditions evoking 
pulmonary eosinophilia as yellow or pinkish stained needle 
crystals29. 
 
Walker K. R. (1982) commented that coils of compressed 
mucus known as Curshmann's spirals were frequently seen in 
sputum from smokers or patient with obstructive airway 
disease, especially asthmatics.  The spirals are casts of the 
small bronchioles and vary considerably in structure, formed 
from inspissated mucus 2, 76. 
 
Schmitz B & Pfitzer(1984) stated that Psammoma bodies 
(Calcospherites) are laminated non-refractile calcified 
concretions sometimes found in the presence of malignancy, 
although not necessarily closely associated with tumour cells72.  
Isolated psammoma bodies may be seen in the absence of any 
tumour formation.  
 
 15 
In 1986, a study by Roggli et al of asbestos body counts 
in lavage fluid from 20 asbestos workers suggested that very 
low counts were non-specific and only high levels were 
indicative of significant industrial exposure. 
 
The ferruginous bodies vary from 5-200µm in length; are 
light brown in colour and stain blue with Perl's stain for iron. 
 
The bronchial washing specimens stained with Prussian 
blue to be more sensitive than sputum for the identification of 
asbestos bodies (Wheeler, TM, et al, 1988). 
 
NON SPECIFIC REACTIVE CHANGES IN CYTOLOGICAL 
PREPARATIONS 
 
1956, PapanicolaouG.N. first observed ciliocytophthoria, 
a degenerative process affecting bronchial epithelium whereby 
columnar cells fragment into rounded cytoplasmic remnants, 
some of which still show tufts of cilia while other contain 
pyknotic nuclear material.  This change was first observed in 
association with viral infections65. In 1961, Papanicolaou and 
his associates revealed that this change can be seen in a range 
of acute and chronic pulmonary diseases, and in cases of 
bronchial carcinoma64. 
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Squamous metaplasia 
 
Squamous metaplasia is one of the commonest 
responses of bronchial epithelium to persistent injury44, 59 
(Nasiell, M, 1965). 
 
It is preceded by reserve cell hyperplasia and is a 
frequent finding in smokers 4, 60, 70. 
 
Reactive Squamous cells:  They have slightly enlarged 
hyper chromatic nuclei and have come to be known as pap cells 
since first described by Dr. George Papanicolaou in his own 
sputum, due to laryngitis 61. 
 
Hyperplasia of Bronchial Epithelium is induced by 
many different noxious agents.  In simple repair processes, 
sheets of actively regenerating cuboidal to columnar cells, with 
enlarged nuclei, fine chromatin and prominent nucleoli are 
seen. 
 
Reserve Cell Hyperplasia is less easily recognized 
especially in sputum.  Groups of small cohesive crowded cells 
with high nuclear / cytoplasmic ratio and dense chromatin are 
typical.  Nuclear moulding may be present, hence confused with 
small cell carcinoma. Absence of necrosis and cell dissociation, 
uniformity of nuclear size and shape are helpful features 56. 
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Hyperplasia of type II pneumocytes and bronchiolar cells 
 
The cells are polygonal or rectangular, occurring singly or 
in two or threes and may show cytoplasmic vacuolation. Nuclei 
are swollen with prominent nucleoli and pale or dense 
chromatin.  They differ from hyperplastic bronchial cells in 
lacking cilia and are not associated with columnar or goblet 
cells nor with reserve cells. 
 
CYTOLOGY OF RESPIRATORY INFECTIONS 
 
The role of the cytology laboratory in the diagnosis of 
opportunistic infection of the lower respiratory tract merits major 
considerations, because a number of these infectious agents 
readily lend them to detection and correct diagnosis by cytologic 
methods and principles. 
Bacterial Pneumonia 
 
Sputum samples are commonest specimens.   In 1981 
Lazzari and associates explained that higher bacteria such as 
actinomyces organism have a more definitive appearance, 
forming colonies of radiating filamentous gram positive bacteria, 
which may be visible in microscopic samples as ‘sulphur 
granules’ 48. 
 
An  analysis undertaken in Brazil by Tani et al in 1987 75 
of over 100 tuberculosis cytology samples other than FNAs 
revealed increased numbers of macrophages in 100%, excess 
neutrophilis in 98% and increased lymphocytes in 85% of the 
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specimens.  Epithelioid cells were present in 56% and giant 
cells in only 40% of the samples. 
 
In 1989, Strigle S. M. and Gal A. A. explained that lavage 
fluid from cases of AIDS with tuberculosis typically contain 
many lymphocytes and enlarged foamy macrophages,  but it is 
unusual to find  a frankly granulomatous picture in these 
samples 74. 
 
In 1992, Chrell S.R. et al revealed that, the organism 
nocardia stains faintly pink by the Papanicolaou method, 
exhibits negative staining with MGG and is well demonstrated 
by Grocott's silver stain. 
 
Viral infections 
 
In contrast to pneumonia due to bacteria, viral infection 
frequently induces specific cytopathic changes enabling the 
pathologist to give a firm indication of the causative agent. 
 
Beale A.J. and Campbell W.A. (1959) explained 
multinucleation of epithelial cells as the characteristic feature of 
measles pneumonia, producing tightly clustered hyper 
chromatic nuclei at the center of the cell cytoplasm.  
Eosinophilic inclusion in both nucleus and cytoplasm may be 
seen in these multi nucleated cells 8. 
 
Naib Z. M. et al (1968) revealed that multi nuclear giant 
cells are the hallmark of Respiratory Syncitial Viral infection 57. 
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Jain et al (1973) described basophilic inclusions in the cell 
cytoplasm during the course of illness 38. 
 
Warner et al 77 described the cytological findings in 
cytomegalovirus virus infection.Large inclusion bodies appear in 
the nuclei of macrophages and other cells of the respiratory 
tract in the course of infection.  They are surrounded by a halo 
and the nuclear membrane is thickened giving an Owl's eye 
appearance. The number of inclusions is said to reflect the 
intensity of the infection 1. 
 
Sprigs A. I. et al (1982) stated that in viral infections 
clumps of hyper plastic epithelial cells may lead to a false 
diagnosis of adenocarcinoma. 
 
Intranuclear inclusion bodies, loss of nuclear chromatin 
pattern, multi nucleation and cytoplasmic inclusion - The best 
recognized of these changes are seen in Herpes virus hominis 
infections (1983). 
 
Fungal infections 
 
Infections and allergy are the two most important 
pathological effects produced in the lung by fungi. The presence 
of fungi in respiratory specimens raises one of three possibilities 
           First, they may be the contaminants from the mouth or 
atmosphere. 
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 Secondly, there may be saprophytic colonization of an 
area of pre-existing diseased lung such as a cavity, without any 
invasion of tissues. 
 
 Thirdly, there could be an active infection (mycosis), with 
growth of fungi in the lung parenchyma. 
 
Blastomyces dermatidis, Cryptococcous neoformans, 
Coccidioides immitis, Histoplasma capsulatum, Candida 
albicans, Paracoccidioides brasiliensis, Aspergillus species are 
the few fungi which are identified in cytology specimens. 
 
Aspergillus infection is a leading cause of death among 
immuno compromised patients. Cytologically, Aspergillus is a 
septate fungus having parallel walls with 450 angled branching. 
 
Khan F. W. et al (1986), after a study of 82 immuno 
compromised patients undergoing bronchoscopic evaluation of 
new pulmonary infiltrates concluded that BAL sample was a 
rapid and effective technique for diagnosing invasive pulmonary 
Aspergillosis in the immuno compromised host.  
  
Unfortunately, lavage had a low sensitivity for detecting 
Aspergillus, in the range of approximately 50%. 
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Parasitic Infections 
 
In 1985, Orenstein and associates reported a sensitivity of 
94.4% using broncho alveolar lavage for the diagnosis of 
Pneumocystis carinii pneumonia in AIDS patients 62. 
 
 
 
NON - INFECTIVE GRANULOMATOUS LUNG DISEASE 
 
 
Infections such as tuberculosis are responsible for most of 
the treatable granulomatous diseases of lung but there are 
numerous other important disorders associated with granuloma 
formation, like sarcoidosis which is a systemic disease of 
unknown etiology affecting mainly young or middle aged 
patients, especially women.  The respiratory tract is involved in 
over 90% of cases.  Cellular immunity is depressed 
systemically, but there are increased numbers of activated T 
lymphocytes, especially T helper cells, at sites of granuloma 
formation 37, 68. 
 
Epithelioid histiocytes are the most characteristic feature, 
either dissociated or in clusters of spindle shaped cells with pale 
cytoplasm and elongated foot print shaped nuclei.  Single cells 
are more often seen in sputum and washings. 
 
Lymphocytes are found in abundance, especially in 
lavage fluid, reflecting profuse lymphocytic exudates into the 
alveoli while the disease is active.  The lymphocytes are 
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predominantly of T cell type, constituting 10-70% of the 
inflammatory cell population, and are mainly T helper cells.        
Healthy non-smokers have levels below 7% 43.  
 
 The ratio of lymphocytes to neutrophil polymorphs, 
macrophages and other inflammatory cells is helpful in 
supporting the diagnosis of sarcoidosis and in monitoring 
response to treatment or progression of the disease. 
 
             In the BAL specimens of patients with active 
tuberculosis and sarcoidosis, there is increased proportion of 
lymphocytes, predominantly activated T cells 36. The CD-4/CD-8 
ratio of lymphocytes was increased in sarcoidosis but not in 
tuberculosis. 
 
 A CD4/CD8 ratio ≥ 2.5 and the CD3/CD4 ratio≤ 0.31 in 
broncho alveolar lavage lymphocytes are commonly seen in 
sarcoidosis45. 
 
HYPERSENSITIVITY PNEUMONITIS 
 
 Most commonly, hypersensitivity results from the 
inhalation of organic dust containing antigens made up of 
spores of thermophilic bacteria, true fungi, animal proteins, or 
bacterial products. 
 
Farmer’s lung results from exposure to dusts generated 
from harvested humid, warm hay that permits the rapid 
proliferation of the spores of thermophilic actinomycetes. 
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   Pigeon breeder’s lung (bird fancier’s disease) is provoked 
by proteins from serum, excreta, or feathers of birds.  Humidifier 
or air-conditioner lung is caused by thermophilic bacteria in 
heated water reservoirs. 
 
 Bronchoalveolar lavage specimens obtained during the 
acute phase show increased levels of proinflammatory 
chemokines such as MIP-1α and IL-8. 
 
 Bronchoalveolar lavage specimens also consistently 
demonstrate increased number of T lymphocytes of both CD4 + 
and CD8 + phenotypes. 
 
 Histological changes in sub acute and chronic forms are 
characteristically centered on bronchioles.  They include, 
1. Interstitial pneumonitis consisting primarily of 
lymphocytes, plasma cells, and macrophages 
2. Non caseating granulomas in two thirds of patients. 
3. Interstitial fibrosis and obliterative bronchiolitis    
In more than half the patients, there is also evidence of an 
intra-alveolar infiltrate. 
 
Langerhans’ cell Histiocytosis 
 
 Langerhans’ cell histiocytosis in the lung is part of 
spectrum of diseases characterized by monoclonal proliferation 
and infiltration of many organs by Langerhans’ cells.  The 
disease can occur as a single isolated nodule and mimic 
carcinoma of the lung. 
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 When suspected clinically, the diagnosis can be 
supported by BAL in which more than 5% of large mononuclear 
cells are CD1a positive 5, 19. 
 
INTERSTITIAL LUNG DISEASE AND PULMONARY FIBROSIS 
 
 Fibrosis of the lung develops either within alveolar spaces 
following active inflammation, resulting in fibrosing alveolitis or 
in the alveolar walls leading to interstitial fibrosis.  In some 
patients both processes occur simultaneously. 
 
           The onset may be acute and severe as in the Hamman 
Rich syndrome, or insidious with gradual progression, the 
common course in idiopathic pulmonary fibrosis.  An important 
subgroup includes patients with bronchiolitis obliterans in whom 
low grade inflammation and fibrosis affect the small airways. 
  
 In most cases cytology cannot determine the cause of the 
disease process but some indication as to prognosis and 
effectiveness of treatment can be obtained by monitoring 
inflammatory cell ratios in broncho alveolar lavage fluid. 
 
There may be a predominant of neutrophil polymorphs, as 
exemplified by early idiopathic pulmonary fibrosis, occupational 
dust disease and collagen vascular disorders.  These patients 
usually show an associated increase in macrophage and 
lymphocyte counts as well. 
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           In the second group lymphocytes predominate, with 
virtually complete absence of polymorphs.  Sarcoidosis and 
extrinsic allergic alveolitis are examples of this pattern.  In 
sarcoidosis the lymphocytes are mainly of T helper subtype, 
whereas in extrinsic allergic alveolitis T suppressor cells 
predominate. 
 
          There may be marked eosionophilia in eosinophilic 
pneumonia and to a lesser extent in cryptogenic fibrosing 
alveolitis. The chest x ray shows diffuse infiltrates and broncho 
alveolar lavage fluid contains more than 25% eosinophils.  
There is a prompt response to corticosteroids. 
 
Diffuse Alveolar Damage 
 
 Diffuse alveolar damage is the result of injury to distal 
alveoli from a single injurious event, usually within the prior few 
days to weeks. There are a great variety of causes including 
inhalants, drugs, oxygen toxicity, irradiation, shock, and sepsis. 
 
 Histologically there is an early, acute phase characterized 
by pulmonary edema, a proteinaceous exudates, and hyaline 
membrane formation.  This is followed in a few days or a week 
by hyperplasia of type II pneumocytes in what is apparently a 
reparative effort. The damage may resolve or may be followed 
by organization and fibrosis.  
 
Cytologic samples obtained by BAL early in the course of 
the disease consist of amorphous proteinaceous material, 
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alveolar macrophages, neutrophils, and atypical type II 
pneumocytes9. (Beskow et al, 2000) 
   
Drug - Induced pulmonary toxicity 
 
 Therapeutic agents may injure the lung directly by 
cytotoxic effects or a hypersensitivity reaction, or they may 
induce systemic conditions which in turn are associated with 
damage to the lung.  A clear cut history of drug exposure is 
necessary for diagnosis. 
 
 Increased neutrophils are seen in lavage fluid in 
bleomycin induced toxicity, and are also a feature of other drug 
reactions (Ex: Gold therapy). 
 
 An unusual cytological picture has been documented with 
the anti arrhythmic drug amiodorone, which, in addition to 
causing damage to pneumocytes and pulmonary fibrosis, also 
produces changes in alveolar macrophages. 
 
         In lavage fluid the macrophages comprise up to 85% of 
the cell population and develop pale lacy cytoplasm due to the 
presence of numerous osmiophilic inclusion bodies, derived 
from damaged lysosomes. 
 
Adult respiratory distress syndrome (ARDS) 
 This serious form of lung damage was first described by 
Ashbaugh and associates in 1967 at which time it carried a 
mortality rate of nearly 70%. 
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 The syndrome follows conditions such as severe trauma, 
pancreatitis or septicemia, developing within 1-3 days of these 
catastrophic illnesses, with the onset of acute pulmonary edema 
and inflammation accompanied by proliferation of type II 
pneumocytes and fibroblasts. 
 
           Local release of highly reactive free oxygen radicals and 
of enzymes such as proteases from neutrophils is postulated to 
cause direct damage to the lung parenchyma. Rapidly 
progressive pulmonary fibrosis may follow. 
 
 The cytological findings in adult respiratory distress 
syndrome have been recorded by Grotte et al (1990).He 
described exfoliation of clusters of hyper plastic broncho 
alveolar cells as seen in many other types of lung damage. 
 
           BAL has also been studied in adult respiratory distress 
syndrome (Hyers and fowler). This potentially lethal disorder is 
a complication of prolonged exposure to high concentration of 
oxygen. It is characterized by the presence of polymorpho 
nuclear leucocytes and high molecular weight plasma proteins 
in the lavage specimen, reflecting the increased permeability of 
damaged capillaries and interstitial tissues in alveolar septa. 
Organ transplantation 
 
               The lung is the seat of many of the complications 
arising in patients who have had organ transplantation, 
regardless of the nature of the transplant.  
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          A recent and important application of BAL is detecting 
rejection and infection in recipients of lung transplants. 
Rejection is heralded by an increase in percentage of 
polymorphonuclear leucocytes in the lavage specimen 18, 35.  
 
Industrial exposure to chemicals and dusts 
 
 Originally described in 1958 as farmer's lung, the 
underlying mechanism is a hypersensitivity pneumonitis, also 
known as extrinsic allergic alveolitis.  It is an industrial hazard in 
a wide range of occupations in which there is exposure to 
moulds or animal proteins. 
 
 Lavage specimens show a raised lymphocyte count with 
an excess of T suppressor cells and sometimes of cytotoxic T 
cells. 
 
 Mineral pneumoconiosis may result from inhalation of 
dusts, gases or mineral fibers.  Lavage fluid from cases of 
silicosis and other related pneumoconiosis shows raised levels 
of polymorphs initially and may also have increased numbers of 
lymphocytes and macrophages. 
 
        BAL specimens obtained in the acute phase show 
increased levels of proinflammatory chemokines such as MIP-
1α and IL-8. 
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       BAL specimens also consistently demonstrate increased 
numbers of T lymphocytes of both CD4+ and CD8+ 
phenotypes. 
 
Pulmonary Alveolar Proteinosis 
 
 This rare disease was associated with known exposure to 
dusts in about half of the cases originally described by Rosen et 
al in 1958, but the condition is probably multifactorial in origin, 
and there is a strong association with immunosuppression.  
Lavage specimens are opaque or milky on gross inspection.  
 
 Rounded fragments of amorphous material of variable 
size, with amphophilic or eosinophilic staining properties are 
seen on light microscopy.  Few if any inflammatory cells are 
seen.                                                                      
 
           Electron microscopy is necessary for a definitive 
diagnosis, revealing rounded lamellated structures identical to 
the osmiophilic bodies of type II pneumocytes and composed of 
surfactant. 
 
Thermal injury 
 
 A neutrophilic response in alveoli and airways is an early 
event.  Healing is accompanied by squamous metaplasia.  
Reversible atypical squamous metaplasia has been observed in 
firemen. 
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 A study by Clark et al of broncho alveolar lavage cells in 
42 fire victims revealed that respiratory tract damage was 
greatest when smoke inhalation was accompanied by 
cutaneous burns. 
 
 Cytological findings include thick mucoid sputum or 
bronchial samples, many damaged epithelial cells, increased 
polymorphs and macrophages in lavage fluid. Squamous 
metaplasia occurs early.  Secondary infection is common. 
 
Role of Cytology in diagnosis of Non-Neoplastic pulmonary 
disease 
 
 1. The first and most reliable is in confirmation of a 
diagnosis of infection by recognition of the causative agent or its 
cytopathic effects.  Cytology provides a relatively cheap, quick, 
non-invasive and dependable method of diagnosis for these 
cases. 
 
 2. The next contribution lies in recognition of characteristic 
changes in respiratory tract samples which, when combined 
with clinical information, give direction or add weight to the 
clinical diagnosis. 
 
 3. Thirdly, negative findings in cytology are of value 
clinically since they contribute to the evidence required to 
exclude malignancy. 
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Table 1: BAL Cellular patterns as an adjunct to 
diagnosis21 
Cellular Diagnosis 
Lymphocytic Hypersensitivity pneumonitis 
Tuberculosis 
Sarcoidosis 
Beryliosis 
Malignant Infiltrates 
Drug induced pneumonitis 
HIV infection 
Neutrophilic Idiopathic pulmonary fibrosis 
Bacterial pneumonia 
Asbestosis 
Acute respiratory distress syndrome 
Wegener’s Granulomatosis 
Eosinophilic Hyper eosinophilic syndrome 
Allergic broncho pulmonary aspergillosis 
Eosinophilic pneumonia 
Churg-Strauss syndrome 
Mixed cellularity Bronchiolitis obliterans organizing 
pneumonia (BOOP) 
Non specific interstitial pneumonia 
Inorganic dust disease 
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TUMOURS OF LUNG 
 
 While respiratory cytodiagnosis had its birth in the late 
1800s, rigid bronchoscopic biopsy was the standard method of 
obtaining specimens for definitive diagnosis as a basis for 
management until the advent of flexible fibreoptic bronchoscopy 
in the 1960s. 
                  
  
GENERAL APPROACH TO CYTOLOGICAL DIAGNOSIS OF 
NEOPLASIA 
  
The cytological appearance of the common lung 
malignancies vary in different types of specimen. 
 
Samples taken by fibreoptic bronchoscopy are best 
examined together. 
 
It is recommended that correlation of cytological and 
histological material should be done before final reports are 
issued.   
 
Such correlation enhances sensitivity of diagnosis, 
optimizes tumour typing and may prevent confusion if material 
with different appearances is present in biopsy and cytological 
samples. 
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 A 100% predictive value of malignant diagnosis is the 
aim, because cytological diagnosis is to be used for definite 
management decisions 15, 16. 
 
SQUAMOUS CELL CARCINOMA 
                      
 This form of lung carcinoma is usually located centrally 
within the lung in main bronchi or branches. The cytological 
diagnosis of squamous cell carcinoma from sputum samples or 
bronchial washings depends on the identification of abnormal 
squamous cells with malignant nuclear criteria, including 
enlargement, dense hyperchromasia, angularity and irregular 
chromatin distribution or 'black ink' chromatin. 
 
Sequence of epithelial events in the development of 
bronchogenic epidermoid carcinoma 
 
Squamous metaplasia without atypia 
Mild squamous dysplasia 
Moderate squamous dysplasia 
Severe squamous dysplasia 
Carcinoma in situ (keratinizing and non keratinizing type) 
Invasive carcinoma 
 
Cytopathologic Findings of squamous dysplasia 
 
Dysplasia is cytologically graded based on nuclear 
morphology, amount of cytoplasm, and nuclear/cytoplasmic 
(N/C) ratios; the higher the ratio, the less differentiated the cell 
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is and the higher the grade of dysplasia.  Cells are present 
isolated, in aggregates, and in tissue fragments. 
 
 Benign squamous metaplastic cells are round when 
present singly.  When seen in tissue fragments, they show a 
honeycomb pattern with well-defined cell borders and small 
central nuclei with low nuclear to cytoplasmic ratio.  Their 
cytoplasm is either cyanophilic or oxyphilic. 
 
          Mildly dysplastic cells are generally normal sized 
squamous metaplastic cells with slightly enlarged nuclei and 
granular chromatin with minimal increase in N/C ratio. 
 
 Moderately dysplastic cells may show variation in size 
with modestly enlarged nuclei containing coarsely granular 
chromatin.  The cytoplasm is decreased in amount and may 
exhibit dyskeratosis. 
 
 Severely dysplastic cells tend to be very pleomorphic in 
size with variable cytoplasm that may or may not be 
dyskeratotic.  The N/C ratios are likewise variable.  Nuclear 
chromatin tends to be coarsely granular and deeply stained.  
Pyknosis is frequent.  Nucleoli are not visualized. 
 
          As with any dysplastic lesion in the body, the diagnosis of 
pre neoplasia should be made with great caution in the 
presence of active chronic inflammation and also adult 
respiratory distress syndrome. 
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          Similarly previous chemotherapy or radiotherapy may 
cause misdiagnosis. These latter two conditions should be 
suspected if there are large cells, with bizarre nuclei and 
plentiful cytoplasm 
 
 SQUAMOUS CELL CARCINOMA 
 
 In 1935, a Finnish investigator, Lindberg, observed that 
squamous metaplasia is a frequent finding in the bronchi of 
patients with lung cancer.   
 
Subsequent histologic studies, notably by Auerbah et al 
(1957) 3 supported this observation and squamous metaplasia 
was considered to be an important step in the genesis of 
bronchogenic squamous carcinoma. 
 
This form of lung carcinoma is usually located centrally 
within the lung and present as hilar and perihilar masses. The 
tumors have a special tendency to undergo central necrosis 
with cavitations. 
 
The cytological diagnosis of squamous cell carcinoma 
depends on the identification of abnormal squamous cells with 
malignant nuclear criteria including enlargement, dense 
hyperchromasia, angularity and irregular   chromatin distribution 
of ‘black ink’ chromatin. 
 
        Histologically the tumor is characterized by the presence of 
keratinisation and intercellular bridges. Keratinisation takes the 
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form of squamous pearls or individual cells with markedly 
eosinophilic dense cytoplasm. 
 
Morphologic variants of squamous cell carcinomas include: 
 
1. Papillary or verrucous type, 
 
2. Small cell variant, 
 
3. Basaloid type, 
 
4. Clear cell type, and 
 
5. Spindle cell (sarcomatoid)/Carcino sarcoma 
 
Adenocarcinoma  
  
 Friedrich (1939), Rossle (1943), and later Spencer (1985) 
pointed out the association of peripheral lung cancers, mainly 
adenocarcinomas, with sub pleural scars 27, 69. 
 
  Alveolar interstitial fibrosis is almost always present at 
the margins of scarring in the lung, regardless of cause, and is 
associated with reparative hyperplasia of bronchiolar and 
alveolar epithelial cells, a change that was thought to precede 
neoplasia in some cases. 
 
  The occurrence of bronchioloalveolar carcinoma in 
patients with scarring due to tuberculosis, cystic lung disease, 
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or long-standing scleroderma (progressive systemic sclerosis) 
of the lung are cited as examples of neoplasia arising in the 
epithelial hyperplasia that accompanies alveolar septal 
fibrosis63. 
 
  However, Shimosato et al (1982) have made a 
persuasive argument that most scars associated with lung 
cancer are formed after the tumor develops, and are caused by 
fibrosis in the areas of tumor necrosis. 
 
 Shimosato (1982) suggested that atypical adenomatous 
hyperplasia (AAH) of bronchoalveolar epithelium may arise in 
otherwise unremarkable lung tissue as a precursor of peripheral 
adenocarcinomas of the lung73. 
 
 Pneumocytes type II as well as Clara cells may participate 
in the pathogenesis of bronchioloalveolar carcinoma have been 
amply confirmed by histochemistry, electron microscopy, and 
immunopathology11, 54. 
 
This is a malignant epithelial tumor with glandular 
differentiation or mucin production by the tumor cells. These 
lesions are usually more peripherally located and tend to be 
smaller. Peripheral adenocarcinomas are sometimes 
associated with areas of scarring. Cavitation is extremely 
unusual. 
 
             Adenocarcinoma appear in cytologic material as both 
single cells and cell clusters, cytoplasm homogenous to 
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extremely vacuolated, round to oval enlarged nuclei and finely 
granular chromatin. Centrally placed macro nucleoli is a 
prominent feature in adenocarcinomas of acinar type 
 
              Cell groups in specimens of adenocarcinoma consist of 
ball like clusters, papillary fragments, loose clusters or true acini 
with central lumina.    
 
          The two morphologic signs of glandular differentiation, 
often found together are formation of tubules or papillae and 
secretion of mucin. 
                
The most recent (1999) World Health Organisation’s 
(WHO) classification of lung tumours has proposed three major 
categories for adenocarcinomas: 
 
Adenocarcinoma 
          Acinar 
 Papillary 
          Bronchioloalveolar adenocarcinoma 
          Nonmucinous type                                      
          Mucinous type 
          Solid adenocarcinoma with mucin production 
Rare variants of adenocarcinoma 
 
           Signet ring adenocarcinoma 
           Mucinous carcinoma 
           Adenocarcinoma with enteric and hepatoid differentiation 
           Adenocarcinoma with choriocarcinomatous foci    
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Bronchioloalveolar Carcinoma 
 
BAC present as single peripheral nodule, multiple nodules 
and diffuse pneumonic- like infiltrate. 
 
           Histopathologically the mucinous type is formed by well 
differentiated mucin containing columnar cells that line 
respiratory spaces without invading the stroma. A sharp 
separation is often found between the neoplastic and normal 
cells, a useful diagnostic feature. 
 
          The cells of non mucinous type of BAC are cuboidal 
rather than columnar and have bright eosinophilic cytoplasm. 
Nuclear atypia and nucleolar prominence are greater than in 
mucinous variety. Hobnail cells and apical spouts may be 
present. 
 
BAC tends to exfoliate both as single cells and cell 
groups.  The nuclei are characteristically round to oval and 
uniform in size, with finely granular or powdery chromatin and 
small, inconspicuous nucleoli.  A minority of cases, however, 
show prominent nucleoli.  Nuclear folds are commonly present 
and in some cases nuclear pseudo inclusions are observed. 
 
 The cytoplasm varies in amount from modest to abundant 
and, like that of other adenocarcinomas, may be homogenous, 
granular, finely vacuolated, or distended by single or multiple 
large vacuoles. 
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Small Cell Carcinoma 
 
This tumour comprises 10 -20 % of all lung cancers. It is 
typically a lesion of central portion of lung. 
 
Histopathologically the pattern of growth is generally solid 
but there may be streams, ribbons, rosettes and pseudo 
rosettes or tubules and ductules. 
 
         The classic form of small cell carcinoma is characterized 
by small round or oval cells resembling lymphocytes. The nuclei 
are finely granular and hyper chromatic, nucleoli are 
inconspicuous, mitoses are frequent and cytoplasm is so 
scanty. 
 
Nuclear moulding a change first described in cytologic 
smears can also be appreciated in microscopic preparations. 
 
         Cytological findings are elongated groupings of small 
dissociating tumour cells, with scant cytoplasm, irregular 
moulded nuclei, coarsely stippled chromatin and inconspicuous 
nucleoli .Degenerative changes are common. 
 
              The WHO classification subdivides small cell 
carcinomas into those of oat cell type, where tumour cells are 
shrunken and more poorly preserved, tumours of intermediate 
type, with slightly more cytoplasm and larger better preserved 
nuclei, and combined carcinomas including areas of squamous 
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or adenocarcinoma; the latter constitute up to 10% of small cell 
tumours. 
 
 Bauer and Erozan reported psammoma bodies in a case 
of oat cell type of small cell carcinoma 7. 
 
Large Cell Undifferentiated Carcinoma 
 
               Undifferentiated large cell carcinomas are pleomorphic 
malignant epithelial cells without definite evidence of either 
squamous or glandular differentiation. This tumour is composed 
of solid sheets of relatively uniform large tumour cells.    
 
              This neoplasm exfoliates large numbers of diagnostic 
cells that appear in respiratory specimens both as large single 
cells and syncytial groups.  Cytoplasm usually cyanophilic and 
varies from granular to foamy with ill defined outlines. 
 
             Nuclei are round to lobulated with irregularly dispersed, 
intensely staining chromatin. Nucleoli may be large and vary in 
number from cell to cell. No evidence of keratinization is seen, 
and insufficient cytoplasmic differentiation is seen to warrant a 
diagnosis of adenocarcinoma. 
 
Variants of large cell undifferentiated carcinoma 
              Giant cell carcinoma 
              Lymphoepithelioma like carcinoma 
     Large cell neuroendocrine carcinoma and non-small  
                cell carcinoma with neuro endocrine features 
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Safeguards against over diagnosis of malignancy  
 
In general, numerous clusters containing many cells are 
more suggestive of malignancy, whereas smaller groupings and 
single cells are more typical of alveolar cell hyperplasia. 
 
The process of cilia around the periphery of cell clumps 
indicates a reactive rather than a neoplastic process. 
                                                                                                      
SARCOMAS     
 
Primary pulmonary sarcomas are very uncommon and 
few are intra bronchial origin. Those that arise in the lung 
seldom erode the bronchial wall and they do not exfoliate easily. 
 
The most common are leiomyosarcoma, malignant fibrous 
histiocytoma and fibro sarcoma, but precise classification of 
tumor type by cytology is difficult (Guiccon & Rossen) 32. A 
specific classification requires histologic material and often a 
battery of immuno stains. 
 
Further it should be emphasized that malignant spindle 
cells in sputum or a bronchial aspirate are much more likely to 
be derived from a spindle cell or sarcomatoid carcinoma. 
 
 It is quite possible for a sarcoma of lung to be 
misinterpreted as spindle cell carcinoma. Conversely a 
mistaken diagnosis of sarcoma may be due to exfoliated cells of 
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a primary or metastatic spindle cell carcinoma in lung 
(Nakajiima 1999)58.       
 
Metastatic Carcinoma 
 
Metastatic tumours to the thorax constitute up to 15-20% 
of lesions diagnosed by cytology in some series42.  Detailed 
knowledge of the clinical history must be available, together 
with earlier cytological and histopathological preparations for 
review and comparison with current material14, 40. 
 
Metastatic tumour, particularly renal cell and colonic 
carcinomas12, may mimic primary tumours clinically either by 
growing as an endobronchial lesion or because of a 
bronchioloalveolar growth pattern. 
 
Cytologically aggregates of tumour cells stand out in clean 
background.  Cell blocks, special stains, immunocytochemistry 
helpful. 
 
Some metastases are recognizable morphologically. For 
example, metastatic well differentiated colonic carcinoma often 
presents with pallisaded, elongated nuclei in aggregates and in 
a background of confluent necrosis26. 
 
BAL was also very effective in the diagnosis of 
lymphangitic carcinomatosis caused by metastatic cancer 49. 
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LYMPHOMA, LEUKAEMIA AND RELATED DISORDERS 
 
Non-Hodgkin’s lymphomas of extra pulmonary origin and 
of all histological subtypes quite frequently affect the lung during 
the course of the disease. 
 
Hodgkin’s lymphoma is rarely seen as primary lung 
lesions79, but the lung is a common site of relapse, particularly 
for nodular sclerosing disease. Tumour deposits are usually 
nodular and may cavitate or produce endobronchial lesions. 
 
Confirmation of recurrent tumour is often possible 
cytologically; on the other hand, definitive diagnosis of primary 
lymphoma generally requires open biopsy.  Respiratory 
samples often provide a preliminary cytological diagnosis.  
However, sufficient material for immunophenotyping and / or 
genotyping is usually considered necessary for definitive 
diagnosis.  It has been suggested that BAL samples may be 
useful for this purpose22 and that immunoelectrophoresis of 
lavage fluid may also prove monoclonality30. 
 
More readily diagnosed by BAL or FNA than in sputum. 
Large cell lymphomas are easier to diagnose than small / 
mixed. Loosely aggregated lymphoid cells, intact cytoplasm, 
vesicular nuclei, no moulding, and visible nucleoli are the 
features. Sub typing is possible in BAL and FNA material. 
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MATERIAL AND METHODS 
 
The present study was carried out in the Department of 
pathology, Madurai Medical College, Madurai, India for a period 
of 2 years from July 2006 to June 2008. 
 
The cytological materials were obtained in the form of 
broncho alveolar lavage fluid using fiber optic bronchoscope. 
Specimens were collected from the Department of Thoracic 
Medicine, Government Rajaji Hospital, Madurai. During this 2 
year study period 132 BAL samples were collected. 
 
Details of the patients such as clinical history, personal 
history, and radiological investigations including details of 
bronchoscopy findings if any were recorded. The working 
proforma is appended in annexure l.  
 
Cytology;  
 
The whole sample was taken in equal volumes in two 
clean glass test tubes and centrifuged for 5 minutes, at a speed 
of 2000 rpm. After centrifugation, the supernatant fluid was 
discarded and the sediments in the test tubes were pooled and 
smears were made on two clean grease free slides.  
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One of the smears should be air dried and stained with 
Giemsa’s stain6.  The other one should be kept in coplin jar 
containing isopropyl alcohol for 10-15 minutes and stained with 
Hematoxylin and eosin stain.  
 
 
Histopathology;  
 
The histopathology specimens of lung biopsy were fixed 
in 10% neutral buffered formalin. The tissues were processed, 
paraffin blocked, 5 microns thin sections were cut and stained 
with Hematoxylin and Eosin33.  
 
Special stains such as PAS were used as and when 
required. Immuno histochemical studies39 were done in relevant 
cases (Annexure Ill). 
 
The results of histopathological study of H and E stained 
sections and cytological study of BAL were entered in the 
proforma. Photomicrographs of the smears and sections were 
taken whenever needed. 
 
 
The information collected was recorded in a master chart. 
The results of both procedures were compared. The nature of 
study performed was cross sectional study. ‘P’ value analysis 
was used for statistical calculation to arrive at the conclusion.  
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Sensitivity, specificity and accuracy were calculated using 
the following formulae and taking HPE findings as the Gold 
standard. 
 
Diagnosis Screening 
test results Diseased Not Diseased 
Positive True positive 
        TP 
False positive 
         FP 
Negative False negative 
        FN 
True negative 
         TN 
                       
 
 
Sensitivity = TP/ (TP+FN) X 100 
 
Specificity= TN/ (FP+TN) X 100 
 
Accuracy = TP+TN/ (TP+FP+FN+TN) X 100 
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RESULTS 
 
 
 
In the present study, a total of 132 Broncho Alveolar 
samples were studied in the Department of Pathology, Madurai 
Medical College, Madurai during the period of July 2006 –June 
2008 
 
As per the proforma, the clinical data was collected from 
the patients who had undergone the BAL and biopsy 
procedures. After studying the BAL and biopsy samples, 
following observations were documented 
 
In the present study, bronchoscopy was performed using 
flexible fiber optic bronchoscope followed by broncho alveolar 
lavage for 132 patients. The study was undertaken in patients 
presented with respiratory symptoms and radiologically visible 
pulmonary lesions. 
 
 Out of 132 BAL smears studied the diagnosis of 
malignancy was given in 36(27.2%) cases, dysplasia in 20 
(15.2%) cases and 52(39.4%) cases were diagnosed as non 
neoplastic inflammatory lesions. The sample was inadequate to 
evaluate in 24 cases.   
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Histopathological correlation was available for 45 cases in 
which 30(66.7%) cases were diagnosed as malignant lesions, 
5(11.1%) cases were dysplastic and 10(22.2%) cases were non 
neoplastic inflammatory lesions. 
 
 
Sex Distribution 
 
 
Out of the total 132 BAL cases, 110 cases (83.3%) were 
males and 22 cases (16.7%) females (Table 3 and chart 1).M: F 
Ratio =5:1. 
 
Out of the 45 biopsy samples studied 41 were males and 
4 females. 
 
Age incidence 
 
In the present study, the age group of patients ranged 
from 16 years to 80 years and the maximum numbers of cases 
were found in the age group of 51-60 years, comprising a total 
of 31.8% of the (42 cases) study population. 
 
The least number of cases were in the age group of 71-80 
years among males comprising only 0.75% of the study 
population (Table 4 and chart 2).  
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Among females, no cases were found in the age groups 
of 11-20 years, and 61-80 years. 
 
 The youngest patient among males was 16 year old and 
the oldest patient was 72 year old. 
 
The youngest patient among females was 28 year old and 
the oldest patient was 60 year old.  
 
 
Mean age of cases (Lesion based) 
 
In the present study the mean age for malignant lesions  
for males was 52.16 years, for females was 50.75 years and the 
mean age for both sexes was 52.00 years . 
 
 For dysplasia the mean age for males was 53.94 years 
for females was 46.75 years and the mean age for both sexes 
was 52.50 years 
 
For inflammatory lesions the mean age for males was 
51.93 years, for females were 39.7 years and the mean age for 
both sexes was 49.54 years (Table 5 and chart 3). 
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Smoking habit distribution 
 
Table 6 shows that significantly higher numbers of 
smokers (84 cases) were present among male population.  
  
In total 63.6% of study population were smokers and 36.4 
% were non- smokers.  None of the female patients (22 cases) 
were smokers (chart 4). 
 
Clinical symptoms 
 
Majority of the patients presented with clinical symptom 
(Table7 and chart 5) of cough followed by fever, 
breathlessness, hemoptysis and fever. Among the 132 cases 
cough was the presenting symptom in 126 cases (95.5%). 
Fever was one among the presenting symptoms in 64 cases 
(48.5%). 
 
 
Breathlessness and hemoptysis were present in equal 
number of cases (41 cases-31.1%). Weight loss was seen in 30 
cases (22.7%). 
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Cytological diagnosis in 132 cases 
 
Of the 132 cases, 108 cases had satisfactory smear.  The 
diagnosis of malignancy was given in 36 cases, dysplasia in 20 
cases, and 52 cases were diagnosed as non neoplastic 
inflammatory lesions.  The sample was inadequate to evaluate 
in 24 cases (Table 8 and chart 6, 7). 
 
 
In our study, majority of BAL samples showed features of 
inflammatory smear, comprising 52 cases, followed by 36 cases 
of malignancy and 20 cases of dysplastic lesions.  
 
 
  Among the 52 inflammatory cases, one known case of 
pulmonary tuberculosis on treatment showed chronic 
inflammatory smears and collections of epithelioid cells. 
 
 
In the 36 malignant lesions diagnosed, 32 cases were 
males and 4 females.  16 males and 4 females were diagnosed 
as having dysplastic lesions.  Among the 52 inflammatory 
lesions, 42 were males 10 were females. 
 
During the study period 132 BAL samples were received 
for cytological examination. Out of these 132 samples, 45 cases 
had biopsy samples.  
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Out of the 45 smears studied, 11 cases(24.4%) were 
malignant lesions(Fig 9), 3cases(6.7%) were squamous cell 
carcinoma(Fig 4,5), 4 cases (11.1%)were adenocarcinoma (Fig 
3),one case of undifferentiated carcinoma (Fig6,7,8),7 
cases(15.6%) were dyaplastic and 15 cases (33.3%) were 
inflammatory smears (Fig 2). 4 cases had inadequate smears 
for evaluation. 
 
Histopathological diagnosis 
 
The Histopathological diagnosis offered for the 45 cases 
is shown in table 9 (chart8, 9). Out of the 45 cases studied 30 
cases (66.7%) were malignant lesions, 5 were dysplastic 
(11.1%) and 10 (22.2%) were non neoplastic lesions. 
 
Among males, there were 28(68.3%) cases of malignant 
lesions, 5(12.3%) cases of dysplastic lesions and 8(19.5%) 
cases of inflammatory lesions. 
  
Among females, there were equal number of cases of 
malignant (2 cases) and non neoplastic lesions (2 cases). 
 
 
 
Distribution of malignant lesions in smokers 
 
 
Histopathological correlation was available for 45 cases in 
which 30 cases were diagnosed as malignant lesions.  
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 Among the 30 cases, 22 cases were smokers and males. 
The remaining 6 males and 2 females were non smokers. 
 
 It is observed (Table 10 and chart 10) that the malignant 
lesions of the lung were more common in smokers than non 
smokers. 
 
Distribution of malignant lesions on histopathology 
 
 
It is observed that there was no significant association 
between distribution of malignant lesion and sex of the patient. 
Out of the 30 cases of malignancy diagnosed in histopathology 
28 were male and 2 were female. Majority of the cases were 
squamous cell carcinoma (Table 11 and chart 11).  
 
 
Among males 11 cases were squamous cell 
carcinoma(Fig 18,19,20,21), 7 were adenocarcinoma (Fig 12), 3 
cases of poorly differentiated adenocarcinoma (Fig 
14,15,16,17), 2 cases of poorly differentiated carcinoma (Fig 
13),  3 cases of anaplastic carcinoma(Fig 22,23,24), 1 case of 
bronchioloalveolar carcinoma and 1 case of small cell 
carcinoma (Fig 25) was diagnosed. 
 
Among females, 1 case of bronchiolo alveolar carcinoma 
(Fig 10, 11) and 1 case of spindle cell sarcoma/? Sarcomatoid 
carcinoma (Fig 26) was reported. 
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Immunohistochemistry study of the spindle cell tumour 
was done. This tumour was immunoreactive for vimentin (Fig 
28-weakly positive) and non reactive for markers such as 
cytokeratin, desmin and S-100 (Fig 27, 29, 30). Based on the 
marker study, the tumour was diagnosed as high grade fibro 
sarcoma. 
 
Histopathological correlation of BAL cases 
 
Table 12 and 13 shows the histopathological correlation of 
BAL cases. 
 
 
Out of the 30 cases of malignancy diagnosed 
histopathologically, the corresponding BAL smears showed 
malignant cells in 18 cases. In the remaining 12 cases of 
malignancy, BAL did not correlate with histopathological 
diagnosis.  Out of 12 smears 6 showed features of inflammatory 
lesions, 3 were dysplastic and 3 cases were inadequate for 
evaluation. 
 
Out of the 5 cases diagnosed as dysplasia, 3 cases of 
BAL did not correlate with histopathological diagnosis of 
dysplasia.  Out of them, 1 case was inadequate for evaluation, 
1 case showed features of malignancy and 1 showed features 
of inflammatory lesion. 
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Out of the 10 cases of inflammation diagnosed 
histopathologically, 8 cases of BAL showed inflammatory 
smears and 2 cases showed features of dysplasia. 
 
Sensitivity and specificity 
 
Malignant lesions: 
 
 In the present study of 45 cases, the cytological diagnosis 
of malignancy was made in 19 cases, among them 18 cases 
were proved as malignancy in histopathology (True positive). 
One case was falsely diagnosed as malignancy in cytology and 
showed features of dysplasia in histopathology(False 
positive).Malignancy was diagnosed in 12 cases 
histopathologically but the corresponding cytology did not show 
malignant cells(False negative). Neither cytology nor 
histopathology showed malignancy in 14 cases (True negative).    
 
True positive cases 18 
False positive case 1 
True negative cases 14 
False negative cases 12 
 
The sensitivity of BAL cytology in diagnosing malignant lesions 
in our study is 60% while the specificity is 93.3%. The 
diagnostic accuracy is 71.1%. 
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DISCUSSION 
 
 Bronchoalveolar lavage can address many lesions that 
are diffuse or peripherally situated.  The goal of BAL is 
investigation of pathologic conditions situated beyond the range 
of bronchoscopic visualisation. 
 
 Studies using BAL information for clinical correlation rest 
on the general concept that alveolar contents reflect 
parenchymal lung disease (86%). 
 
 
 The present study was conducted to analyse the cellular 
elements recovered from BAL in patients with pulmonary 
lesions.  Based on the cytomorphology of the cells in the BAL, 
cytodiagnosis was provided. The BAL cytodiagnosis was 
correlated in patients who underwent bronchoscopic biopsy. 
 
 
 For the purpose of study, we have taken 132 cases of 
bronchoalveolar lavage samples, from the department of 
pathology, Government Rajaji Hospital, Madurai, during the 
period July 2006 – June 2008.  
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Sex Incidence: 
 
  Out of 132 cases 110 cases were males (83.3%) and 
22(16.7%) cases were females.  The male to female ratio is 5:1 
 
Age Incidence: 
 
In our study, the age of patients ranged between 16 years 
to 72 years. We received the samples from male cases from the 
age group of 11-80 years and the samples from female cases 
were from the age groups of 21-60 years. 
 
 It is observed that, the higher prevalence of respiratory 
diseases were in the age group of 51-60 years among males, 
and in the age group of 41-50 years among females. 
 
 The highest prevalence respiratory diseases among 
males and females were (62.8%) in the age group of 41-60 
years. 
 
Smoking Habit: 
 
 In the present study, out of 110 males 84 were smokers 
and 26 were non smokers. All 22 females were non smokers. It 
is observed that 76.4% of the study population was smokers 
and the habit of smoking is a major risk factor for pulmonary 
diseases. 
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Clinical symptoms: 
  
It is observed that 126 cases (95.5%) suffered with cough 
followed by fever in 64 cases (48.5%), Breathlessness in 41 
cases (31.1%), Hemoptysis in 41 cases (31.1%) and Weight 
loss in 30 cases (22.7%).  So, cough being the most common 
clinical manifestation of patients with pulmonary diseases. 
 
 
Comparison of diagnostic accuracy for malignancy 
with other studies (Table 14): 
 
 
In 1987, Linder J et al studied BAL fluid among 35 cases 
of biopsy proven lung carcinomas.  However 24 cases had cells 
diagnostic of malignancy on cytologic preparation of BAL fluid. 
 
 
In 1992, Piruzynski M et al studied BAL fluid among 145 
cases of biopsy proven lung carcinomas.  Out of these 94 cases 
(64.8%) were found to have malignant disease of lung. 
 
 
The prospective study by de Gracia J et al, in 1993 BAL 
were diagnostic in revealing malignant cells in 24 cases out of 
55 cases with biopsy proven malignancy.   
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In a study by De beljek A et al in 1994, 61 patients were 
biopsy proven malignancies out of which 17 (27.9%) patients 
showed malignant cells in BAL fluid specimen. 
 
In 1998, after studying 30 patients with lung cancers 
Wongsurakiat P et al, reported that BAL was positive for 
malignant cells in 14 patients (46.7%). 
 
In the present study, 30 cases were diagnosed as 
malignant lesions in biopsy and corresponding BAL fluid 
samples examined show malignant cells in 18 cases (71.1%). 
 
In the present study the diagnostic accuracy was 71.1% 
and had a near correlation with the study of Pirozynski M and 
Linder J et al.  
 
Table 15 shows the comparison of histopathological 
diagnosis of lung lesions among BAL Cases with the study by 
Linder J et al 52.In the study by Linder J et al, the biopsy 
diagnosis of patients studied by BAL showed 10 cases of 
squamous cell carcinoma, 15 cases of adenocarcinoma, 7 
cases of large cell undifferentiated carcinoma and 3 cases of 
small cell undifferentiated carcinoma.   
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In the present study, biopsy showed 11 cases of 
squamous cell carcinoma, 7 cases of adenocarcinoma, 2 cases 
of bronchioloalveolar carcinoma, 5 cases of poorly differentiated 
carcinoma, 3 cases of undifferentiated carcinoma, 1 case of 
small cell carcinoma and 1 case of spindle cell tumor (Table 
15). 
 
 
Immunohistochemistry study of spindle cell tumour 
showed reactivity for vimentin and the tumour is non reactive for 
cytokeratin, desmin and S- 100. Based on these observations 
the diagnosis of high grade fibro sarcoma was made. 
   
Most of the patients with carcinoma in the study by Linder 
J et al were smokers and they had prominently neutrophils in 
the background of malignant cells.   
 
In the present study also male patients diagnosed as 
having malignancy showed neutrophils predominantly in the 
background of malignant cells.   
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SUMMARY 
 
 
From the prospective study of BAL cytology done during the 
period of July 2006 – June 2008, the following features were 
observed 
 
1. For the purpose of the study, 132 BAL sample has been 
presented. 
2. Among the 132 cases, 110 cases (83.3%) were males, 
and 22 cases (16.7%) were females. 
3. The youngest patient was 16 year old male, and oldest 
patient was 72 years male. 
4. Among the 132 cases, 84 cases were smokers and all 
were males. 
5. The remaining 26 males and all the 22 females were non- 
smokers. 
6. Majority of the patients presented with clinical symptom 
of cough (95.5%) followed by fever (48.5%), 
breathlessness (31.1%), hemoptysis (31.1%) and weight 
loss (22.7%). 
7. The maximum numbers of cases diagnosed cytologically 
were inflammatory lesions (39.4%). 
8. Malignant, Dysplastic and Inflammatory lesions were 
more common among males (29%, 14.5% and 38.2%) 
respectively when compared to females (18.2%, 18.2% 
and 45.4%). 
9. Histopathological correlation was available in 45 cases of 
which only 28 cases correlated. 
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10. Malignant lesions diagnosed histopathologically were 
more common in smokers. 
11. The habit of smoking increases the risk of pulmonary 
cancer. 
12. The diagnostic accuracy of BAL cytology in diagnosing 
malignant lesions was 71.1%.  
13. Sensitivity and specificity for diagnosing malignant 
lesions by BAL cytology was 60% and 93.33% 
respectively. 
14. The overall diagnostic accuracy of BAL was 71.1% in the 
present study. 
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CONCLUSION 
 
In conclusion a correlative study of broncho alveolar 
lavage cytology and histopathological examination of pulmonary 
lesions revealed the overall sensitivity of 60%, specificity of 
93.33%, and accuracy of 71.1%. 
 
 
The false negative and false positive cases in this study 
can be minimized by proper sampling, screening, and strictly 
adhering to adequacy criteria. 
 
 
The results are quite encouraging and BAL has a valuable 
role and is superior to other ancillary techniques of cytology in 
evaluating the pulmonary lesions, because of its safety, 
accuracy and minimal invasiveness.  
 
 
 
 
 
 
 
 
 
 
 
Table 3: Sex Distribution of all cases 
 
 
 
Sl.No. Sex No. of Cases Percentage 
1. Male 110 83.3% 
2. Female 22 16.7% 
                          Total 132 100% 
           
 
        
 
 
    Chart: 1 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sex Distribution of all cases
22, 17%
Male 
Female 
110, 83%
 
Table 4: Age Distribution of all cases 
 
 
No. of Cases Age Group 
(in years) Male Female Total 
11-20 2 (1.8%) - 2(1.5%) 
21-30 3(2.7%) 4(18.2%) 7(5.3%) 
31-40 11(10%) 3(13.6%) 14(10.6%) 
41-50 30(27.2%) 11(50%) 41(31.0%) 
51-60 38(34.5%) 4(18.2%) 42(31.8%) 
61-70 25(22.7%) - 25(18.9%) 
71-80 1(0.9) - 1(0.75%) 
Total 110(99.8%) 22(100%) 132(99.9%) 
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Table 5: Mean age of cases (lesion based) 
 
 
NO. OF CASES MEAN  
 
MALE 
 
FEMALE 
 
TOTAL 
 
MALE 
 
FEMALE 
 
TOTAL 
 
MALIGNANCY 
 
32 
 
4 
 
36 
 
52.16 
 
50.75 
 
52.0 
 
DYSPLASIA 
 
16 
 
4 
 
20 
 
53.94 
 
46.75 
 
52.50 
 
INFLAMMATORY 
 
42 
 
10 
 
52 
 
51.93 
 
39.7 
 
49.54 
 
INADEQUATE 
 
20 
 
4 
 
24 
 
51.90 
 
44.25 
 
50.63 
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      Table 6: Smoking habit distribution of all cases  
 
 
 
Habit Male Female Total 
Smoker 84(76.4%) - 84(63.6%) 
Non-Smoker 26(23.6%) 22(100%) 48(36.4%) 
Total 110(100%) 22(100%) 132(100%) 
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        Table 7: Clinical symptoms of all cases  
 
 
Found in  Sl. 
No 
Clinical 
Symptoms No. of cases Percentage 
1 Cough 126 95.5% 
2 Fever 64 48.5% 
3 Breathlessness 41 31.1% 
4 Hemoptysis 41 31.1% 
5 Weight loss 30 22.7% 
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Table 8: Cytological diagnosis in 132 BAL samples 
 
 
No. of Cases Sl. 
No Lesion Male Female 
Total 
1 Malignant 32(29%) 4(18.2%) 36(27.2%) 
2 Dysplasia 16(14.5%) 4(18.2%) 20(15.2%) 
3 Inflammatory 42(38.2%) 10(45.4%) 52(39.4%) 
4 Inadequate 20(18.2%) 4(18.2%) 24(18.2%) 
Total 110(100%) 22(100%) 132(100%) 
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     Table 9: Histopathological diagnosis of biopsy in 
45 samples  
 
 
No. of Cases Sl. 
No Lesion Male Female Total 
1 Malignant 28(68.3%) 2(50%) 30(66.7%)
2 Dysplastic 5(12.3%) - 5(11.1%) 
3 Inflammatory 8(19.5%) 2(50%) 10(22.2%)
Total 41(100%) 4(100%) 45(100%)
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Table 10: Distribution of malignant lesions among 
smokers 
 
 
 Non-Smokers Smokers Total 
Male 6 22 28 
Female 2 - 2 
Total 8 22 30 
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Table 11: Distribution of Malignant Lesions on 
Histopathology 
 
 
No. of Cases Sl. 
No 
Lesion 
Male Female 
Total 
1 Squamous Cell Carcinoma 11(39.3%) - 11(%36.7) 
2 Adeno Carcinoma 7(25) - 7(23.3%) 
3 Bronchiolo alveolar 
Carcinoma 
1(3.6%) 1(50%) 2(6.7%) 
4 Poorly differentiated adeno 
carcinoma 
3(10.7%) - 3(10.0%) 
5 Poorly differentiated 
carcinoma 
2(7.1%) - 2(6.7%) 
5 Anaplastic carcinoma 3(10.7%) - 3(10.0%) 
6 Small cell carcinoma 1(3.6%) - 1(3.3%) 
     
7 
Spindle cell sarcoma /? 
Sarcomatoid carcinoma 
- 1(50%) 1(3.3%) 
Total 28(100%) 2(100%) 30(100%) 
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Table 12: Comparison of Cytological diagnosis of BAL with histopathological diagnosis 
 
 
Final Histopathological Diagnosis 
Cytological  
Diagnosis NSI 
 
DYS 
 
SCC AC BAC PDAC PDC UDC SmCC 
Spindle 
cell 
tumour 
Total 
 M F M F M F M F M F M F M F M F M F M F  
INF 6 2 1  2  2  1  1          15 
Malignancy   1  3  3   1   1  2      11 
SCC     3                3 
AC     1  1    2          4 
UDC               1      1 
DYS 2  2  1  1      1        7 
IA   1  1            1   1 4 
TOTAL 8 2 5 - 11 - 7 - 1 1 3 - 2 - 3 - 1 - - 1 45 
 
 
M – Male, F – Female, NSI – Non – Specific Inflammation, DYS – Dysplasia , SCC – Squamous cell carcinoma,   
AC – Adeno Carcinoma, BAC – Bronchiolo alveolar carcinoma, PDAC – Poorly Differentiated Adeno Carcinoma,  
PDC – Poorly Differentiated Carcinoma, UDC – Undifferentiated Carcinoma, INF – Inflammation, IA - Inadequate
 
 
 
 
 
 
 
 
 
 
 
Table 13: Histopathological Correlation of BAL Cases  
 
 
Lesions Total C NC 
Malignant 30 18 12 
Dysplastic 5 2 3 
Inflammatory 10 8 2 
Total 45 28 17 
 
Table 14: Comparison of diagnostic accuracy for   
  malignancy with other studies 
 
 
 
Study 
Total No. of 
proven 
malignancies 
No. of cases 
diagnosed 
in BAL 
Diagnostic 
accuracy (%) 
Linder J et al 52 35 
 
24 68.6 
Pirozynski M 66 145 94 64.8 
De Gracia J et al 24 55 24 43.6 
Debeljek A et al 23  61 17 27.9 
Wongsurakiat et al 78 30 14 46.7 
Present Study 30 18 71.1 
 
 
 
 
Table 15: Comparison of histopathological diagnosis of  
                 lung lesions among BAL Cases with the study  
                 by Linder J et al 52 
 
Undifferentiated 
Carcinoma Study SCC PDC SmCC ADC BAC 
Spindle 
cell 
tumour Large Cell 
Small 
Cell 
Linder J 
et al 88 
10 
(29%) 
- - 15 
(43%) 
- - 7 
(20%) 
3 
(8%) 
Present 
Study 
11 
(36.7%) 
5 
(16.7%) 
1 
(3.3%) 
7 
(23.3%) 
2 
(6.7%) 
1 
(3.3%) 
3 
(10%) 
- 
 
 
 
 
 
 
 
 
 
 
Table 2:  Diagnostic BAL findings 21 
 
Sl.No. BAL findings Diagnosis 
1 Pneumocystis carinii, fungi, 
cytomegalovirus transformed 
cells 
Opportunistic infections 
2 Milky effluent, periodic acid 
Schiff positive non cellular 
corpuscles, amorphous debris, 
foamy macrophages 
Alveolar proteinosis 
3 Hemosiderin laden 
macrophages, intra cytoplasmic 
fragments or red blood cells in 
macrophages, free red blood 
cells 
Alveolar hemorrhage 
syndrome 
4 Malignant cells of  solid tumors, 
lymphoma, leukemia 
Malignant infiltrates 
5 Dust particles in macrophages, 
quantifying asbestos bodies 
Dust exposure 
6 Eosinophils greater than 25% Eosinophilic lung disease 
7 Positive lymphocyte 
transformation test to beryllium 
Chronic beryllium disease 
8 CD1 positive Langerhan’s cells 
increased 
Langerhans cell 
histiocytosis 
9 Atypical hyper plastic type II 
Pneumocytes 
Diffuse alveolar damage, 
drug toxicity 
 
  
ANNEXURE – I 
 
PROFORMA 
 
BRANCHO ALVEOLAR LAVAGE CYTOLOGY IN 
PULMONARY LESIONS  
 
1. Name :    Age:  Sex: 
 
2. Address :    Unit:  Ward: 
 
 
       IP / OP No.: 
 
       Cytology No.: 
 
3. Presenting Complaints 
 
 
 a. Fever  b. Cough 
 
 c. Expectoration d. Hemoptysis  
 
 e. Chest Pain f. Breathlessness 
 
 g. Loss of appetite h. Weight loss 
 
 
4. Past History: 
 
 
5. Treatment History: 
 
6. Personal History:    Smoker 
 
     Non-Smoker 
 
 
7. Occupational History: 
 
 
8. Family History: 
 
  
9. Investigations: 
 
 A. Hematological  B. Biochemical 
 
 C. Radiological Diagnosis 
 
  X-ray chest 
 
  CT scan 
D. Fiber optic Bronchoscopic findings: 
 
E. Others 
 
10. Clinical Diagnosis: 
 
 
11. BAL Cytology: 
 
 Specimen  : Adequate / Inadequate 
 
 Squamous Cell : Metaplastic / Dysplastic /  
                                          Malignant 
 
 Columnar Cell : Reactive / Malignant 
 
Inflammatory Cells: Neutrophils / Eosinophils /   
Lymphocytes / Macrophages 
 
 Non-cellular material: 
 
 Background : 
 
 Organism  :  Fungi 
 
 
12. Histopathological Correlation if any: 
 
 
13. Special study if any: 
 
 
14. Final Diagnosis: 
  
 
ANNEXURE - II 
ELECTIVE BRONCHOSCOPY AND BAL 
 
Patient Preparation 
 
1. Fasting before the procedure to reduce the risk of 
aspiration (> 8 hours preferable) 
2. Informed consent 
3. Optional premedication (e.g. 0.5 mg atropine, IM to 
reduce secretions) 
4. Topical anesthesia (e.g. 0.45% tetracaine) 
 
Routine monitoring during bronchoscopy 
  
 Continuous pulse oximetry 
 Blood pressure 
 Heart rate and 
 A continuous electro cardiogram 
 
All patients should receive supplemental oxygen during and 
after the procedure. 
 
 The flexible bronchoscope can be inserted either trans 
nasally or transorally.  We prefer trans nasal approach, because 
it is simple.  When using the trans nasal approach, the nasal 
fossa and nasophayrnx should be carefully examined before the 
flexible bronchoscope is passed into the larynx. 
 
  
 Once the larynx is reached, advancement of the 
bronchoscope is halted. At this point the vocal cords can be 
anesthetized, examined for normal abduction and adduction 
and assessed for pathology (polyps, lesions, and erythema).  
Next the flexible bronchoscope is passed through the cords and 
the circumference of the trachea is carefully examined for 
mucosal changes and lesions, external compressions and 
abnormalities of the cartilaginous rings. 
 
 Then the carina is examined for splaying, position and 
mucosal abnormalities.  All segmental bronchial orifices are 
inspected systematically with careful attention paid to their 
color, texture, position, relative size, patency and the presence 
of splaying.  The bronchial mucosa should be assessed 
carefully to identify sub mucosal infiltration, degree of acute or 
chronic inflammation and nature and quantity of secretion. 
 
 A variety of sampling techniques, including bronchial 
washing, bronchial brushing, BAL, Endobronchial or 
transbronchial forceps biopsy and endobronchial or trans 
bronchial needle aspiration, allows the operator to collect 
specimens from the respiratory tract. 
 
 The goal of BAL is investigation of pathological conditions 
situated beyond the range of bronchoscopic visualization. 
 
 The bronchoscope is physically wedged into the 
bronchus.  Warmed saline is then used to flood the bronchial 
  
and alveolar tissue distal to this point.  Up to one million alveoli 
may thus be sampled. 
 
  Fluid is introduced in aliquots that may range from 20 to 
100 ml or more.   After each fluid instillation, the bronchus is 
aspirated, and in most instances, up to 50% of the initial fluid 
volume is recovered. 
 
 Differential washings are an accepted part of the 
procedure, the first to remove bronchial luminal content and the 
second to provide a good alveolar sample53. 
 
  Up to 30% of routinely submitted samples may have a 
paucity of macrophages, an excess of bronchial epithelial cells, 
a mucopurulent component or degenerative changes rendering 
them unsuitable for assessment17. 
 
 A series of four or five separate instillations follows in 
rapid succession.  The returned fluid can be used for cytological 
examination and enumeration with differential counting of 
inflammatory cells and in microbiologic studies. 
 
 The first aliquot is often heavily contaminated with upper 
aero digestive tract material, the presence of which makes it 
difficult to evaluate pulmonary parenchymal disorders. 
 
 Thus excluding this first sample, pooling the remaining 
three of four aliquots for the studies is suggested by many 
investigators. 
  
The aspirated bronchio alveolar lavage sample sent 
immediately to the laboratories in sterile labeled containers 
without adding any fixatives. 
  
The samples were accompanied by appropriately filled 
requisition form. After receiving the BAL fluid sample in the 
laboratory, it was verified with the request form. 
 
Then the whole sample was taken in equal volumes in two 
clean glass test tubes and centrifuged for 5 minutes, at a speed 
of 2000 rpm.  
 
After centrifugation, the supernatant fluid was discarded 
and the sediments in all the test tubes were pooled and smears 
were made on two clean grease free slides. 
 
One of the smears should be air dried and stained with 
Giemsa’s stain.  The other one should be kept in coplin jar 
containing isopropyl alcohol for 10-15 minutes and stained with 
Hematoxylin and eosin stain.  
 
Broncho alveolar lavage specimen adequacy:   
Assessment based primarily on cell counts. 
At least 2 x 106 total cells obtained. 
More than ten macrophages per high power microscopic 
field(Fig 1). 
More than 25 macrophages per high power field in the presence 
of upper tract contamination or acute inflammatory exudates. 
 
  
 
Unsatisfactory: 
 
Based primarily on other criteria 
Excessive squamous or bronchial cells (epithelial cells > 
macrophages). 
Excessive  degeneration. 
Excessive red blood cells, especially if other adequacy 
problems exist. 
 
Factors affecting the cellular yield of Broncho alveolar 
lavage in Healthy controls. 
 
Patient Factors: 
Smoking without chronic bronchitis yields more macrophages 
Smoking with chronic bronchitis yields more neutrophils. 
 
Procedural factors: 
Lung area studied 
Volume instilled (aliquot size and number of aliquots). 
 
Preparatory factors: 
Separate processing of the first (bronchial) aliquot 
Gauze filtration to remove mucus and bronchial cells. 
Cytocentrifugation causes selective loss of lymphocytes. 
Membrane filtration causes selective loss of neutrophils.  
 
 
 
  
Bronchoalveolar lavage is used with a high degree of 
success   both for diagnostic and therapeutic purposes. 
 
 
Diagnostic Application of BAL 
 
1. For the detection of opportunistic infections in 
Immunocompromised hosts 
2. In the detection of lung cancers 
3. Evaluation of interstitial lung diseases 
4. Pneumonia in immunocompromised patients to rule out 
an infectious process and to identify the offending 
microorganisms. 
5. Persistent and unexplained pulmonary infiltrate in both 
immunocompromised and immunocompetent patients. 
6. In patients with idiopathic pulmonary hemosiderosis, 
pulmonary interstitial disease, and drug toxicity. 
7. To monitor drug response by performing differential 
count. 
8. In post transplant patients, to monitor the progress, 
identify acute and chronic rejection and infections. 
9. Useful in identification of lipid-filled histiocytes in 
aspirations pneumonias. 
10. To confirm fat embolization from infarcted bone 
marrow in acute chest syndrome in sickle cell disease. 
11. Identify leukemic infiltrate. 
12. To confirm histiocytosis X, by identifying Langerhan    
       cells. 
 
  
ANNEXURE - III 
MAY– GRUNWALD – GIEMSA TECHNIQUE 6 
 
Stock stain          -    Giemsa powder 0.38 gm 
                                        Glycerin 25 ml 
                                  Methyl alcohol 25 ml 
 
 
Working solution - To 1 ml of stock solution add 10 ml                        
of distilled water 
 
 
STAIN PROCEDURE 
 
 Immerse air dried BAL smears in May – Grunwald 
working stain for 15 minutes. Rinse gently in tap water. 
Immerse smears in Giemsa stain for 15 minutes. Rinse gently in 
tap water. Allow to air dry. Dip in xylene and mount in DPX. 
 
 
 
 
 
 
 
 
 
 
 
  
IMMUNO HISTOCHEMICAL STAINING 39 
 
1.      Sections to alcohol 
2. Block endogenous peroxidase activity by incubating in    
hydrogen peroxide solution for 30 minute. 
3. Hydrate sections by passing through graded ethanol 
series and wash in running water for 15 minutes. 
4. Incubate sections in the normal swine serum diluted in 
Tris / saline for 15 minutes. 
5. Drain off excess Tris buffered normal swine serum. 
6. Incubate sections with primary antiserum diluted 1; 2000, 
1:1000, 1:250 and 1:100 in 1% normal swine serum for 30 
minutes. 
7. Jet wash off excess antiserum and then wash slides in 
Tris/ saline for three 2 minutes changes. 
8. Incubate sections in swine anti rabbit IgG diluted 1:20 for 
30 minutes. 
9. Jet wash of excess antiserum and then wash slides for 
three 2 minutes changes. 
10. Incubate sections in PAP complex diluted 1: 60 in 1% 
normal swine serum  in Tris / saline for 30 minutes. 
11. Jet wash off excess complex and wash in Tris / saline for 
three 2 minutes changes. 
12. Incubate sections in DAB medium for 5 minutes. 
13. Wash sections in running water for 10 minutes 
14. Counterstain in alum haematoxylin, dehydrate clear  
15. and mount. 
Results : Reaction product ….. Brown. 
Nuclei ….. Blue 
  
 
PERIODIC ACID SCHIFF TECHNIQUE  
 
1. Bring sections to water 
2. Oxidize for 5-10 minutes in 1% aqueous periodic acid. 
3. Wash in running water for 5 minutes and rinse in distilled 
water 
4. Treat with Schiff reagent for 10-30 minutes 
5. Transfer to directly to first sulphite rinse for 1 minute and 
to the second sulphite rinse for 2 minutes. Transfer to the 
third sulphite rinse for 2 minutes. 
6. Wash for 10 minutes in running water. 
7. Counter stain with haematoxylin. 
8. Dehydrate, clean and mount in D.P.X. 
 
RESULT:  
 
PAS positive substances are bright red in colour 
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CODES 
 
 
M-Male                         
F-Female                                                                                    
S-Smoker                                                                                                 
NS-Non smoker             
Dys-Dysplasia              
INF-Inflammatory         
IA-Inadequate  
A - Squamous cell carcinoma 
B - Adenocarcinoma 
C - Bronchioloalveolar carcinoma  
D - Poorly differentiated adenocarcinoma 
E - Poorly differentiated carcinoma  
F - Anaplastic carcinoma 
G - Small cell carcinoma 
H - Spindle cell sarcoma / Sarcomatoid carcinoma 
 
 
 
 
 
 
 
 
 
